ALTO-300 in Depression
Trial Summary
Will I have to stop taking my current medications?
You can continue taking your current SSRI, SNRI, or bupropion if you've been on a stable dose for at least 6 weeks. However, you cannot use certain other medications like tricyclic antidepressants, melatonin, or antipsychotics during the trial.
How does the drug ALTO-300 (Agomelatine) differ from other treatments for its condition?
What is the purpose of this trial?
This trial studies ALTO-300, a treatment, to understand its effects on various patients. Researchers aim to find indicators that show how effective ALTO-300 is.
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive ALTO-300 oral tablet daily for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- ALTO-300
ALTO-300 is already approved in European Union for the following indications:
- Major Depressive Disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alto Neuroscience
Lead Sponsor